Interphase cytogenetics of chromosomes 11 and 17 in fine needle aspirates of breast cancer

Human Pathology

Volumn 30, Issue 2, 1999, Pages 137-144

  McManus, Damian T ^a   Patterson, Anna H ^a   Maxwell, Perry ^a   Hamilton, Peter W ^a   Anderson, Neil H ^a   Caughley, Linda M ^a   Toner, Peter G ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Breast cancer; Chromosomes 11 and 17; Fine needle aspirates; Interphase cytogenetics; Tumor grading

Indexed keywords

ARTICLE; ASPIRATION BIOPSY; BREAST CANCER; CANCER GRADING; CHROMOSOME 11; CHROMOSOME 17; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERPHASE;

EID: 0032978550     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(99)90267-8     Document Type: Article

References (30)

1. Wolfe KQ, Herrington CS: Interphase cytogenetics and pathology: A tool for diagnosis and research. J Pathol 181:359-361, 1997
2. Wolman SR: Applications of fluorescence in situ hybridisation techniques in cytopathology. Cancer Cytopathol 81:193-197, 1997
3. McManus AP, Gusterson BA, Pinkerton CR, et al: Diagnosis of Ewing's sarcoma and related tumours by fluorescence in situ hybridisation detection of chromosome 22q12 translocations on tumour touch imprints. J Pathol 176:137-142, 1995
4. McManus AP, O'Reilly MAJ, Jones KP, et al: Interphase fluorescence in situ hybridisation detection of t (2;13) (q35;q14) in alveolar rhabdomyosarcoma: A diagnostic tool in minimally invasive biopsies. J Pathol 178:410-414, 1996
5. Kallioniemi O, Kallioniemi A, Kurisu W, et al: C-erbB-2 oncogene amplification in breast cancer analysed by fluorescence in situ hybridisation. Proc Natl Acad Sci U S A 89:5321-5325, 1992
6. Matsumara K, Kallioniemi A, Kallioniemi O, et al: Deletion of chromosome 17p loci in breast cancer cells detected by fluorescence in situ hybridisation. Cancer Res 52:3474-3477, 1992
7. Anastasi J, Le Beau M, Vardimiani JW, et al: Detection of numerical chromosome aberrations in neoplastic haemopoetic cells by in situ hybridisation with a chromosome-specific probe. Am J Pathol 136:131-139, 1990
8. Herrington CS, Cooper K, McGeeJO'D: Interphase cytogenetics: Analysis of numerical chromosome aberrations in isolated cells. J Pathol 175:283-295, 1995
9. Devilee P, Thierry RF, Kievits T, et al: Detection of chromosome aneuploidy in interphase nuclei from human primary breast cancers using chromosome-specific repetitive DNA probes. Cancer Res 48:5825-5830, 1988
10. Cajulis RS, Frias-Hidvegi D: Detection of numerical chromosomal abnormalities in malignant cells in fine needle aspirates by fluorescence in situ hybridisation of interphase nuclei with chromosome specific probes. Acta Cytol 37:391-396, 1993
11. Cajulis RS, Kotliar S, Haines GK, et al: Comparative study of interphase cytogenetics, flow cytometric analysis and nuclear grade of fine-needle aspirates of breast carcinoma. Diagn Cytopathol 11:151-158, 1994
12. Herrington CS, Leek RD, McGee J O'D: Correlation of numerical chromosome 11 and 17 imbalance with metastasis of primary breast cancer to lymph nodes. J Pathol 176:353-335, 1995
13. Ichiwaka D, Hashimoto N, Hoshima M, et al: Analysis of numerical aberrations of specific chromosomes by fluorescent in situ hybridisation as a diagnostic tool in breast cancer. Cancer 77:2064-2069, 1996
14. Sauter G, Feichter G, Torhorst MD, et al: Fluorescence in situ hybridisation for detecting erb2 amplification in breast tumour fine needle aspiration biopsies. Acta Cytol 40:164-173, 1996
15. Micale MA, Visscher DW, Gulino SE, et al: Chromosomal aneuploidy in proliferative breast disease. HUM PATHOL 25:29-35, 1994
16. Sneige N, Sahin A, Dinh M, et al: Interphase cytogenetics in mammographically detected breast lesions. HUM PATHOL 27:330-335, 1996
17. Farabegoli F, Ceccarelli C, Santini D, et al: Chromosome 1 aneusomy with 1p36 under-representation is related to histological grade, DNA aneuploidy, high c-erb-B-2 and loss of bcl-2 expression in ductal breast carcinoma. IntJ Cancer 69:381-385, 1996
18. Robinson JA, McKee G, Nichols A, et al: Prognostic value of cytological grading of fine needle aspirates from breast carcinomas. Lancet 343:947-949, 1994
19. Hunt CM, Ellis IO, Elston CW, et al: Cytological grading of breast carcinoma: A feasible proposition? Cytopathology 1:287-295, 1990
20. Trott PA: Pathological assessment in patients receiving primary medical therapy for breast cancer. Cytopathology 7:75-77, 1996
21. Camplejohn RS, Ash CM, Gillet CE, et al: The prognostic significance of DNA flow cytometry in breast cancer: Results from 881 patients treated in a single centre. BrJ Cancer 71:140-145, 1997
22. Shackney SE, Singh SG, Yakulis R, et al: Aneuploidy in breast cancer: A fluorescence in situ hybridisation study. Cytometry 22:282-291, 1995
23. Verdoodt B, Castelain P, Bourgain C, et al: Aneuploidy for chromosome 1 and overall DNA content in benign and malignant breast disease. Cancer Genet Cytogenet 78:53-63, 1994
24. Kibbelaar RE, Kok F, Dreef EJ, et al: Statistical methods in interphase cytogenetics: An experimental approach. Cytometry 14:716-724, 1993
25. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer: Experience from a large study with long term follow up. Histopathology 19:403-410, 1991
26. Pinder SE, Ellis IO, Elston CW: Prognostic factors in primary breast carcinoma. J Clin Pathol 48:981-983, 1995
27. Fiegl M, Tueni C, Schenk T, et al: Interphase cytogenetics reveals a high incidence of aneuploidy and intra-tumoral heterogeneity in breast cancer. BrJ Cancer 72:51-55, 1995
28. Simpson JF, Quan DE, Ho JP, et al: Genetic heterogeneity of primary breast carcinoma defined by fluorescence in situ hybridisation. AmJ Pathol 149:751-758, 1996
29. Anamthawat-Jonsson K, Eyfjord JE, Ogmundsdottir HM, et al: Instability of chromosomes 1,3,16 and 17 in primary breast carcinomas inferred by fluorescence in situ hybridisation. Cancer Genet Cytogenet 88:1-7, 1996
30. Slamon DJ, Clark GM, Wong SG, et al: Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/ neu oncogene. Science 235:177-118, 1987